UK Loses Measles Elimination Status Amid Rising Cases and Declining Vaccination Rates

The United Kingdom has been reclassified by the World Health Organization (WHO) as having re-established measles transmission, losing its previous measles elimination status. This change follows an increase in reported measles cases across the UK in 2024 and a decline in childhood MMR (measles, mumps, and rubella) vaccination rates, prompting public health concerns and calls for enhanced immunization efforts.

WHO Reclassification and European Context

The WHO's European regional verification commission determined that the UK no longer meets the criteria for measles elimination, a status it had maintained between 2021 and 2023. This reclassification places the UK among six countries in Europe and central Asia, including Spain, Austria, Armenia, Azerbaijan, and Uzbekistan, that have lost their measles-free designation. The WHO emphasized that most individuals contracting the disease across Europe were unvaccinated.

The UK's reclassification means it no longer meets the criteria for measles elimination, joining several other European nations in losing this status.

Increase in Measles Cases and Fatalities

In 2024, the UK has recorded 3,681 measles cases. Between 2019 and 2025, there were 20 measles-related deaths, which matches the total number of deaths recorded from 1999 to 2018. A child in Liverpool reportedly died from measles in the summer of the previous year.

A local outbreak in Enfield, north London, infected over 60 children across seven schools and one nursery, with 15 children requiring hospitalization. The director of public health for Enfield, Dudu Sher-Arami, stated that this outbreak posed a risk to the wider capital due to resident travel and London's generally lower vaccination uptake rates.

Declining Vaccination Coverage

Data from the UK Health Security Agency (UKHSA) indicates a decline in MMR vaccination rates in England. The uptake of the first MMR jab for five-year-olds decreased from 91.9% in 2015-16 to 88.9% in 2024-25, reaching its lowest level since 2010-11. Similarly, the proportion of five-year-olds receiving a second MMR vaccine, recommended by the WHO for full immunity, declined from a peak of 88.2% in 2015-16 to 83.7% in 2024-25, marking the lowest level since 2009-10.

The WHO recommends a 95% vaccination rate for herd immunity against measles, mumps, and rubella. In some parts of England, vaccination rates for both MMR doses among five-year-olds have been reported below 60%. For instance, the MMR vaccination rate in Enfield was 64.3%.

Contributing Factors and Health Risks

Health experts and local councils attribute the resurgence of measles to several factors, including reduced MMR vaccination uptake, vaccine hesitancy, and difficulties parents face in securing immunization appointments. Dr. Simon Williams, a public health researcher, noted the influence of social media-based information on vaccine coverage. Dr. Helen Stewart of the Royal College of Paediatrics and Child Health identified policy factors, detailing patient difficulties such as booking appointments, transportation issues, and inconsistent access to general practitioners.

Measles is highly contagious, capable of spreading from one infected person to up to 18 unvaccinated individuals. The disease can cause severe complications, including brain damage, lung damage, meningitis, blindness, and deafness. Approximately one in five children with measles require hospital treatment. Dr. Vanessa Saliba, a consultant epidemiologist at the UKHSA, stated that infections can rapidly return when childhood vaccine uptake decreases.

Calls for System Reform and Government Response

In response to the declining vaccination rates and increasing cases, public health specialists and Members of Parliament have called for a review of the MMR vaccination system. Suggestions include allowing pharmacies to administer MMR jabs, supplementing existing programs run by GP surgeries and schools. Supporters, including Labour MP Ben Coleman and Professor Steve Turner, president of the Royal College of Paediatrics and Child Health, suggest this would make vaccinations more accessible for families. Olivier Picard, chair of the National Pharmacy Association, indicated that the current system's uptake rates suggest a broader health service approach may be needed. Some general practitioners have reportedly expressed opposition to pharmacies being paid for a role traditionally performed by family doctors. The Department of Health and Social Care (DHSC) has not confirmed if pharmacies will begin delivering MMR jabs, though Superdrug has indicated readiness.

The government has launched a campaign encouraging parents to ensure their children are up-to-date with vaccinations, noting that childhood immunizations prevent approximately 5,000 deaths and 228,000 hospitalizations annually in England. From January, children can receive their second MMR dose sooner, and the MMRV vaccine, which also protects against chickenpox, has been introduced into the childhood program. Temporary vaccination clinics have been established in Enfield to address local outbreaks. The WHO has called upon governments to enhance vaccination programs, particularly targeting vulnerable populations, to close immunity gaps.

Future Outlook

Professor Andrew Pollard, director of the Oxford Vaccine Group, warned of a risk of further measles spread, particularly in communities with less than 95% vaccination coverage. He predicted cyclical outbreaks if susceptibility continues to accumulate.